Francis Medical, founded with a mission to innovate therapeutic solutions for prostate, kidney, and bladder cancer, focuses on developing advanced medical devices. Their core product leverages water vapor ablation technology, designed to be tough on cancer while gentle on patients. This novel approach aims to provide effective treatment for endourological cancers, particularly prostate cancer, which is the second most common cancer among American men.
Notable figures associated with Francis Medical include experienced professionals in the medical technology sector and a board of directors with significant industry expertise. The company has attracted investment from leading venture capital firms, underscoring confidence in its innovative approach. Key achievements include the development and clinical testing of their water vapor ablation device, which has the potential to significantly impact cancer treatment protocols and improve patient outcomes.
